| Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity L Meng, R Mohan, BHB Kwok, M Elofsson, NY Sin, CM Crews Proceedings of the National Academy of Sciences 96 (18), 10403-10408, 1999 | 1222 | 1999 |
| The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase BHB Kwok, B Koh, MKI Ndubuisi, M Elofsson, CM Crews Chemistry & biology 8 (8), 759-766, 2001 | 674 | 2001 |
| Targeting bacterial virulence: inhibitors of type III secretion in Yersinia AM Kauppi, R Nordfelth, H Uvell, H Wolf-Watz, M Elofsson Chemistry & biology 10 (3), 241-249, 2003 | 288 | 2003 |
| Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology N Sin, KB Kim, M Elofsson, L Meng, H Auth, BHB Kwok, CM Crews Bioorganic & medicinal chemistry letters 9 (15), 2283-2288, 1999 | 271 | 1999 |
| Small-molecule inhibitors specifically targeting type III secretion R Nordfelth, AM Kauppi, HA Norberg, H Wolf-Watz, M Elofsson Infection and immunity 73 (5), 3104-3114, 2005 | 265 | 2005 |
| A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis S Muschiol, L Bailey, Å Gylfe, C Sundin, K Hultenby, S Bergström, ... Proceedings of the National Academy of Sciences 103 (39), 14566-14571, 2006 | 256 | 2006 |
| Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α', β'-epoxyketones M Elofsson, U Splittgerber, J Myung, R Mohan, CM Crews Chemistry & Biology 6 (11), 811-822, 1999 | 204 | 1999 |
| Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram‐negative bacteria P Keyser, M Elofsson, S Rosell, H Wolf‐Watz Journal of internal medicine 264 (1), 17-29, 2008 | 203 | 2008 |
| Inhibition of Type III Secretion in Salmonella enterica Serovar Typhimurium by Small-Molecule Inhibitors DL Hudson, AN Layton, TR Field, AJ Bowen, H Wolf-Watz, M Elofsson, ... Antimicrobial agents and chemotherapy 51 (7), 2631-2635, 2007 | 163 | 2007 |
| Derivatization procedures for reducing oligosaccharides, part 3: preparation of oligosaccharide glycosylamines, and their conversion into glycosaccharide-acrylamide copolymers E Kallin, H Lönn, T Norberg, M Elofsson Journal of Carbohydrate Chemistry 8 (4), 597-611, 1989 | 147 | 1989 |
| Salicylidene Acylhydrazides That Affect Type III Protein Secretion in Salmonella enterica Serovar Typhimurium A Negrea, E Bjur, SE Ygberg, M Elofsson, H Wolf-Watz, M Rhen Antimicrobial agents and chemotherapy 51 (8), 2867-2876, 2007 | 140 | 2007 |
| Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle L Bailey, Å Gylfe, C Sundin, S Muschiol, M Elofsson, P Nordström, ... FEBS letters 581 (4), 587-595, 2007 | 136 | 2007 |
| Preparation of building blocks for glycopeptide synthesis by glycosylation of Fmoc amino acids having unprotected carboxyl groups LA Salvador, M Elofsson, J Kihlberg Tetrahedron 51 (19), 5643-5656, 1995 | 132 | 1995 |
| Glycopeptides bind MHC molecules and elicit specific T cell responses. CV Harding, J Kihlberg, M Elofsson, G Magnusson, ER Unanue Journal of immunology (Baltimore, Md.: 1950) 151 (5), 2419-2425, 1993 | 127 | 1993 |
| Building blocks for glycopeptide synthesis: glycosylation of 3-mercaptopropionic acid and Fmoc amino acids with unprotected carboxyl groups M Elofsson, B Walse, J Kihlberg Tetrahedron letters 32 (51), 7613-7616, 1991 | 123 | 1991 |
| Removal of acyl protective groups from glycopeptides: Base does not epimerize peptide stereocenters, and β-elimination is slow P Sjölin, M Elofsson, J Kihlberg The Journal of organic chemistry 61 (2), 560-565, 1996 | 115 | 1996 |
| Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds D Wang, CE Zetterström, M Gabrielsen, KSH Beckham, JJ Tree, ... Journal of Biological Chemistry 286 (34), 29922-29931, 2011 | 109 | 2011 |
| Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120 M Elofsson, LA Salvador, J Kihlberg Tetrahedron 53 (1), 369-390, 1997 | 98 | 1997 |
| Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron A Slepenkin, PA Enquist, U Hägglund, LM de la Maza, M Elofsson, ... Infection and immunity 75 (7), 3478-3489, 2007 | 97 | 2007 |
| The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa CE Zetterström, J Hasselgren, O Salin, RA Davis, RJ Quinn, C Sundin, ... PLoS One 8 (12), e81969, 2013 | 93 | 2013 |
Jan KihlbergProfessor i Organisk kemi在 kemi.uu.se 的电子邮件经过验证
